Horizon Therapeutics PLC (NASDAQ:HZNP)
| 111.24 Delayed Data As of Jan 26 |  0.00 / 0.00%Today’s Change | 57.84 Today|||52-Week Range 117.49 | -2.25% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 861.5M | 516.2M | 757.9M | 962.1M | |
| Short Term Investment Cash | 641.9M | -350.6M | 241.7M | 204.2M | ||
| Cash & Short Term Investments | 861.5M | 516.2M | 757.9M | 962.1M | ||
| Receivables | Receivables | 210.4M | 305.7M | 367.4M | 464.7M | |
| Inventories | Inventories | 18.4M | 174.8M | 61.7M | 50.8M | |
| Current Assets | Prepaid Expenses | 11.2M | 28.6M | -- | 5.9M | |
| Other Current Assets | 4.7M | 13.3M | 43.4M | 43.2M | ||
| Current Assets | 1.1B | 1.0B | 1.2B | 1.5B | ||
| Total Assets | Property, Plant and Equipment - Gross | 17.8M | 31.8M | 34.1M | 39.3M | |
| Depreciation | -3.8M | -8.3M | -13.7M | -19.2M | ||
| Intangible Assets | 1.9B | 3.2B | 2.9B | 2.6B | ||
| Other Assets | 1.9B | 3.2B | 2.9B | 2.6B | ||
| Total Assets | 3.1B | 4.3B | 4.2B | 4.1B | ||
| Liabilities | Accounts Payable | 16.6M | 52.5M | 34.7M | 30.3M | |
| Short Term Debt | 4.0M | 7.8M | 10.6M | 0.00 | ||
| Accrued Expenses | 277.7M | 461.7M | 634.5M | 635.0M | ||
| Other Current Liabilities | 289.8M | 483.9M | 655.5M | 653.1M | ||
| Other Liabilities | 357.6M | 605.9M | 757.1M | 761.9M | ||
| Total Liabilities | Long Term Debt | 1.1B | 1.8B | 1.9B | 1.9B | |
| Deferred Taxes | -111.1M | -295.7M | -154.5M | -90.5M | ||
| Other Liabilities | 133.0M | 318.4M | 359.2M | 340.0M | ||
| Total Liabilities | 1.8B | 3.0B | 3.2B | 3.1B | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 1.3B | 1.3B | 991.1M | 1.1B | ||
| Total Shareholder Equity | 1.3B | 1.3B | 991.1M | 1.1B | ||
| Share Information | Common Shares Outstanding | 159.7M | 161.6M | 164.4M | 168.9M | |
| Addtl. Info. | No data currently available for this section. | |||||
